Acumen Pharmaceuticals Q2 2024 GAAP EPS $(0.34) Misses $(0.28) Estimate
Acumen Pharmaceuticals Q2 2024 GAAP EPS $(0.34) Misses $(0.28) Estimate
Acumen Pharmaceuticals Q2 2024 GAAP每股收益爲$(0.34),低於$(0.28)的預期。
Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.28) by 21.43 percent.
Acumen Pharmaceuticals (納斯達克:ABOS)報告本季每股虧損$(0.34),未達到分析師共識預期 $(0.28),下降了21.43%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。